A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31

被引:83
作者
Johanneson, B
Lima, G
von Salomé, J
Alarcón-Segovia, D
Alarcón-Riquelme, ME
机构
[1] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Inst Genet & Pathol,Sect Med Genet, S-75185 Uppsala, Sweden
[2] Inst Nacl ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico
关键词
D O I
10.1086/344289
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A set of 87 multicase families with systemic lupus erythemathosus (SLE) from European (Iceland, Sweden, England, Norway, Italy, and Greece) and recently admixed (Mexico, Colombia, and the United States) populations were genotyped and analyzed for 62 microsatellite markers on chromosome 1. By parametric two-point linkage analysis, six regions (1p36, 1p21, 1q23, 1q25, 1q31, and 1q43) were identified that have LOD scores of Zgreater than or equal to1.50, with different contributions, depending on the population of origin of the families (European or admixed American). All of the regions have been described previously and have therefore been confirmed in this analysis. The locus at 1q31 showed a significant three-point LOD score of Z=3.79 and was contributed by families from all populations, with several markers and under the same parametric model. Analysis of a known mutation in the CD45 gene did not support the role that this mutation plays in disease. We conclude that the locus at 1q31 contains a major susceptibility gene, important to SLE in general populations.
引用
收藏
页码:1060 / 1071
页数:12
相关论文
共 79 条
[31]   TWIN STUDIES IN RHEUMATIC DISEASES [J].
JARVINEN, P ;
AHO, K .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1994, 24 (01) :19-28
[32]   THE PREVALENCE AND INCIDENCE OF SYSTEMIC LUPUS-ERYTHEMATOSUS IN BIRMINGHAM, ENGLAND - RELATIONSHIP TO ETHNICITY AND COUNTRY OF BIRTH [J].
JOHNSON, AE ;
GORDON, C ;
PALMER, RG ;
BACON, PA .
ARTHRITIS AND RHEUMATISM, 1995, 38 (04) :551-558
[33]  
JONSSON H, 1990, BRIT J RHEUMATOL, V29, P185
[34]   The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus [J].
Karlson, EW ;
Daltroy, LH ;
Lew, RA ;
Wright, EA ;
Partridge, AJ ;
Fossel, AH ;
Roberts, WN ;
Stern, SH ;
Straaton, KV ;
Wacholtz, MC ;
Kavanaugh, AF ;
Grosflam, JM ;
Liang, MH .
ARTHRITIS AND RHEUMATISM, 1997, 40 (01) :47-56
[35]   NORMAL B-LYMPHOCYTE DEVELOPMENT BUT IMPAIRED T-CELL MATURATION IN CD45-EXON6 PROTEIN-TYROSINE-PHOSPHATASE DEFICIENT MICE [J].
KISHIHARA, K ;
PENNINGER, J ;
WALLACE, VA ;
KUNDIG, TM ;
KAWAI, K ;
WAKEHAM, A ;
TIMMS, E ;
PFEFFER, K ;
OHASHI, PS ;
THOMAS, ML ;
FURLONGER, C ;
PAIGE, CJ ;
MAK, TW .
CELL, 1993, 74 (01) :143-156
[36]   Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus [J].
Komata, T ;
Tsuchiya, N ;
Matsushita, M ;
Hagiwara, K ;
Tokunaga, K .
TISSUE ANTIGENS, 1999, 53 (06) :527-533
[37]  
Kung C, 2000, NAT MED, V6, P343
[38]   GENETIC DISSECTION OF COMPLEX TRAITS - GUIDELINES FOR INTERPRETING AND REPORTING LINKAGE RESULTS [J].
LANDER, E ;
KRUGLYAK, L .
NATURE GENETICS, 1995, 11 (03) :241-247
[39]  
LAWRENCE JS, 1987, J RHEUMATOL, V14, P913
[40]   A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q [J].
Lindqvist, AKB ;
Steinsson, K ;
Johanneson, B ;
Kristjánsdóttir, H ;
Arnasson, A ;
Gröndal, G ;
Jonasson, I ;
Magnusson, V ;
Sturfelt, G ;
Truedsson, L ;
Svenungsson, E ;
Lundberg, I ;
Terwilliger, JD ;
Gyllensten, UB ;
Alarcón-Riquelme, ME .
JOURNAL OF AUTOIMMUNITY, 2000, 14 (02) :169-178